{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:59:53Z","timestamp":1759341593059,"version":"3.37.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00044-021-02744-3","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T06:02:37Z","timestamp":1622095357000},"page":"1321-1327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting \u03b3-secretase for familial Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5721-9092","authenticated-orcid":false,"given":"Michael S.","family":"Wolfe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"2744_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM. Alzheimer\u2019s disease. N Engl J Med. 2010;362:329\u201344.","journal-title":"N Engl J Med"},{"key":"2744_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","volume":"120","author":"RE Tanzi","year":"2005","unstructured":"Tanzi RE, Bertram L. Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective. Cell. 2005;120:545\u201355.","journal-title":"Cell"},{"key":"2744_CR3","doi-asserted-by":"publisher","first-page":"29621","DOI":"10.1074\/jbc.R800015200","volume":"283","author":"SL Cole","year":"2008","unstructured":"Cole SL, Vassar R. The role of APP processing by BACE1, the \u03b2-secretase, in Alzheimer\u2019s disease pathophysiology. J Biol Chem. 2008;283:29621\u20135.","journal-title":"J Biol Chem"},{"key":"2744_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/353844a0","volume":"353","author":"MC Chartier-Harlin","year":"1991","unstructured":"Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, et al. Early-onset Alzheimer\u2019s disease caused by mutations at codon 717 of the \u03b2-amyloid precursor protein gene. Nature. 1991;353:844\u20136.","journal-title":"Nature"},{"key":"2744_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349:704\u20136.","journal-title":"Nature"},{"key":"2744_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256:184\u20135.","journal-title":"Science"},{"key":"2744_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/359322a0","volume":"359","author":"C Haass","year":"1992","unstructured":"Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, et al. Amyloid \u03b2-peptide is produced by cultured cells during normal metabolism. Nature. 1992;359:322\u20135.","journal-title":"Nature"},{"key":"2744_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature. 1995;376:775\u20138.","journal-title":"Nature"},{"key":"2744_CR9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature. 1995;375:754\u201360.","journal-title":"Nature"},{"key":"2744_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus. Science. 1995;269:973\u20137.","journal-title":"Science"},{"key":"2744_CR11","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid \u03b2-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med. 1996;2:864\u201370.","journal-title":"Nat Med"},{"key":"2744_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nm0197-67","volume":"3","author":"M Citron","year":"1997","unstructured":"Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, et al. Mutant presenilins of Alzheimer\u2019s disease increase production of 42-residue amyloid \u03b2-protein in both transfected cells and transgenic mice. Nat Med. 1997;3:67\u201372.","journal-title":"Nat Med"},{"key":"2744_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(00)80291-3","volume":"17","author":"G Thinakaran","year":"1996","unstructured":"Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 1996;17:181\u201390.","journal-title":"Neuron"},{"key":"2744_CR14","doi-asserted-by":"publisher","first-page":"28415","DOI":"10.1074\/jbc.272.45.28415","volume":"272","author":"G Thinakaran","year":"1997","unstructured":"Thinakaran G, Harris CL, Ratovitski T, Davenport F, Slunt HH, Price DL, et al. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J Biol Chem. 1997;272:28415\u201322.","journal-title":"J Biol Chem"},{"key":"2744_CR15","doi-asserted-by":"publisher","first-page":"24536","DOI":"10.1074\/jbc.272.39.24536","volume":"272","author":"T Ratovitski","year":"1997","unstructured":"Ratovitski T, Slunt HH, Thinakaran G, Price DL, Sisodia SS, Borchelt DR. Endoproteolytic processing and stabilization of wild-type and mutant presenilin. J Biol Chem. 1997;272:24536\u201341.","journal-title":"J Biol Chem"},{"key":"2744_CR16","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1074\/jbc.273.6.3205","volume":"273","author":"A Capell","year":"1998","unstructured":"Capell A, Grunberg J, Pesold B, Diehlmann A, Citron M, Nixon R, et al. The proteolytic fragments of the Alzheimer\u2019s disease-associated presenilin-1 form heterodimers and occur as a 100\u2013150-kDa molecular mass complex. J Biol Chem. 1998;273:3205\u201311.","journal-title":"J Biol Chem"},{"key":"2744_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1006\/nbdi.1997.0129","volume":"3","author":"MB Podlisny","year":"1997","unstructured":"Podlisny MB, Citron M, Amarante P, Sherrington R, Xia W, Zhang J, et al. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol Dis. 1997;3:325\u201337.","journal-title":"Neurobiol Dis"},{"key":"2744_CR18","doi-asserted-by":"publisher","first-page":"16470","DOI":"10.1074\/jbc.273.26.16470","volume":"273","author":"G Yu","year":"1998","unstructured":"Yu G, Chen F, Levesque G, Nishimura M, Zhang DM, Levesque L, et al. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains \u03b2-catenin. J Biol Chem. 1998;273:16470\u20135.","journal-title":"J Biol Chem"},{"key":"2744_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B De Strooper","year":"1998","unstructured":"De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 1998;391:387\u201390.","journal-title":"Nature"},{"key":"2744_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/35017108","volume":"2","author":"Z Zhang","year":"2000","unstructured":"Zhang Z, Nadeau P, Song W, Donoviel D, Yuan M, Bernstein A, et al. Presenilins are required for \u03b3-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1. Nat Cell Biol. 2000;2:463\u20135.","journal-title":"Nat Cell Biol"},{"key":"2744_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/35017105","volume":"2","author":"A Herreman","year":"2000","unstructured":"Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, De Strooper B. Total inactivation of \u03b3-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol. 2000;2:461\u20132.","journal-title":"Nat Cell Biol"},{"key":"2744_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1021\/jm970621b","volume":"41","author":"MS Wolfe","year":"1998","unstructured":"Wolfe MS, Citron M, Diehl TS, Xia W, Donkor IO, Selkoe DJ. A substrate-based difluoro ketone selectively inhibits Alzheimer\u2019s \u03b3-secretase activity. J Med Chem. 1998;41:6\u20139.","journal-title":"J Med Chem"},{"key":"2744_CR23","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1021\/bi982562p","volume":"38","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, Xia W, Moore CL, Leatherwood DD, Ostaszewski B, Donkor IO, et al. Peptidomimetic probes and molecular modeling suggest Alzheimer\u2019s \u03b3-secretases are intramembrane-cleaving aspartyl proteases. Biochemistry. 1999;38:4720\u20137.","journal-title":"Biochemistry"},{"key":"2744_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and \u03b3-secretase activity. Nature. 1999;398:513\u20137.","journal-title":"Nature"},{"key":"2744_CR25","doi-asserted-by":"publisher","first-page":"11223","DOI":"10.1021\/bi991080q","volume":"38","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, De Los Angeles J, Miller DD, Xia W, Selkoe DJ. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer\u2019s disease. Biochemistry. 1999;38:11223\u201330.","journal-title":"Biochemistry"},{"key":"2744_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/35017062","volume":"2","author":"WP Esler","year":"2000","unstructured":"Esler WP, Kimberly WT, Ostaszewski BL, Diehl TS, Moore CL, Tsai J-Y, et al. Transition-state analogue inhibitors of \u03b3-secretase bind directly to presenilin-1. Nat Cell Biol. 2000;2:428\u201334.","journal-title":"Nat Cell Biol"},{"key":"2744_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/35015085","volume":"405","author":"YM Li","year":"2000","unstructured":"Li YM, Xu M, Lai MT, Huang Q, Castro JL, DiMuzio-Mower J, et al. Photoactivated \u03b3-secretase inhibitors directed to the active site covalently label presenilin 1. Nature. 2000;405:689\u201394.","journal-title":"Nature"},{"key":"2744_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0896-6273(03)00205-8","volume":"38","author":"B De Strooper","year":"2003","unstructured":"De Strooper B. Aph-1, Pen-2, and nicastrin with presenilin generate an active \u03b3-secretase complex. Neuron. 2003;38:9\u201312.","journal-title":"Neuron"},{"key":"2744_CR29","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1073\/pnas.052436599","volume":"99","author":"WP Esler","year":"2002","unstructured":"Esler WP, Kimberly WT, Ostaszewski BL, Ye W, Diehl TS, Selkoe DJ, et al. Activity-dependent isolation of the presenilin\/\u03b3-secretase complex reveals nicastrin and a \u03b3 substrate. Proc Natl Acad Sci USA. 2002;99:2720\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2744_CR30","doi-asserted-by":"publisher","first-page":"11794","DOI":"10.1021\/ja037131v","volume":"125","author":"C Das","year":"2003","unstructured":"Das C, Berezovska O, Diehl TS, Genet C, Buldyrev I, Tsai JY, et al. Designed helical peptides inhibit an intramembrane protease. J Am Chem Soc. 2003;125:11794\u20135.","journal-title":"J Am Chem Soc"},{"key":"2744_CR31","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1021\/jm049788c","volume":"47","author":"F Bihel","year":"2004","unstructured":"Bihel F, Das C, Bowman MJ, Wolfe MS. Discovery of a subnanomolar helical D-tridecapeptide inhibitor of \u03b3-secretase. J Med Chem. 2004;47:3931\u20133.","journal-title":"J Med Chem"},{"key":"2744_CR32","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1073\/pnas.0407640102","volume":"102","author":"AY Kornilova","year":"2005","unstructured":"Kornilova AY, Bihel F, Das C, Wolfe MS. The initial substrate-binding site of \u03b3-secretase is located on presenilin near the active site. Proc Natl Acad Sci USA. 2005;102:3230\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2744_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature14892","volume":"525","author":"XC Bai","year":"2015","unstructured":"Bai XC, Yan C, Yang G, Lu P, Ma D, Sun L. et al. An atomic structure of human \u03b3-secretase. Nature. 2015;525:212\u20137.","journal-title":"Nature"},{"key":"2744_CR34","doi-asserted-by":"publisher","first-page":"eaaw0930","DOI":"10.1126\/science.aaw0930","volume":"363","author":"R Zhou","year":"2019","unstructured":"Zhou R, Yang G, Guo X, Zhou Q, Lei J, Shi Y. Recognition of the amyloid precursor protein by human \u03b3-secretase. Science. 2019;363:eaaw0930.","journal-title":"Science"},{"key":"2744_CR35","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1021\/jacs.9b13405","volume":"142","author":"S Bhattarai","year":"2020","unstructured":"Bhattarai S, Devkota S, Meneely KM, Xing M, Douglas JT, Wolfe MS. Design of substrate transmembrane mimetics as structural probes for \u03b3-secretase. J Am Chem Soc. 2020;142:3351\u20135.","journal-title":"J Am Chem Soc"},{"key":"2744_CR36","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1124\/jpet.102.048280","volume":"305","author":"TA Lanz","year":"2003","unstructured":"Lanz TA, Himes CS, Pallante G, Adams L, Yamazaki S, Amore B. et al. The \u03b3-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester reduces A\u03b2 levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice. J Pharmacol Exp Ther. 2003;305:864\u201371.","journal-title":"J Pharmacol Exp Ther"},{"key":"2744_CR37","first-page":"635043","volume":"312","author":"DM Barten","year":"2004","unstructured":"Barten DM, Guss VL, Corsa JA, Loo AT, Hansel SB, Zheng M, et al. Dynamics of \u03b2-amyloid reductions in brain, cerebrospinal fluid and plasma of \u03b2-amyloid precursor protein transgenic mice treated with a \u03b3-secretase inhibitor. J Pharm Exp Ther. 2004;312:635043.","journal-title":"J Pharm Exp Ther"},{"key":"2744_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/jpet.103.060715","volume":"309","author":"TA Lanz","year":"2004","unstructured":"Lanz TA, Hosley JD, Adams WJ, Merchant KM. Studies of A\u03b2 pharmacodynamics in the brain, cerebrospinal fluid, and plasma in young (plaque-free) Tg2576 mice using the \u03b3-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY-411575). J Pharmacol Exp Ther. 2004;309:49\u201355.","journal-title":"J Pharmacol Exp Ther"},{"key":"2744_CR39","doi-asserted-by":"publisher","first-page":"7487","DOI":"10.1073\/pnas.131202798","volume":"98","author":"BK Hadland","year":"2001","unstructured":"Hadland BK, Manley NR, Su D, Longmore GD, Moore CL, Wolfe MS, et al. Secretase inhibitors repress thymocyte development. Proc Natl Acad Sci USA. 2001;98:7487\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2744_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.semcdb.2020.05.019","volume":"105","author":"G G\u00fcner","year":"2020","unstructured":"G\u00fcner G, Lichtenthaler SF. The substrate repertoire of \u03b3-secretase\/presenilin. Sem Cell Dev Biol. 2020;105:27\u201342.","journal-title":"Sem Cell Dev Biol"},{"key":"2744_CR41","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrm1406","volume":"5","author":"R Kopan","year":"2004","unstructured":"Kopan R, Ilagan MX. \u03b3-secretase: proteasome of the membrane? Nat Rev Mol Cell Biol. 2004;5:499\u2013504.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2744_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev.neuro.26.041002.131334","volume":"26","author":"D Selkoe","year":"2003","unstructured":"Selkoe D, Kopan R. Notch and presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci. 2003;26:565\u201397.","journal-title":"Annu Rev Neurosci"},{"key":"2744_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/387288a0","volume":"387","author":"PC Wong","year":"1997","unstructured":"Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME, et al. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature. 1997;387:288\u201392.","journal-title":"Nature"},{"key":"2744_CR44","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0092-8674(00)80244-5","volume":"89","author":"J Shen","year":"1997","unstructured":"Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell. 1997;89:629\u201339.","journal-title":"Cell"},{"key":"2744_CR45","doi-asserted-by":"publisher","first-page":"12876","DOI":"10.1074\/jbc.M311652200","volume":"279","author":"GT Wong","year":"2004","unstructured":"Wong GT, Manfra D, Poulet FM, Zhang Q, Josien H, Bara T, et al. Chronic treatment with the \u03b3-secretase inhibitor LY-411,575 inhibits \u03b2-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem. 2004;279:12876\u201382.","journal-title":"J Biol Chem"},{"key":"2744_CR46","doi-asserted-by":"publisher","first-page":"46107","DOI":"10.1074\/jbc.M307757200","volume":"278","author":"GH Searfoss","year":"2003","unstructured":"Searfoss GH, Jordan WH, Calligaro DO, Galbreath EJ, Schirtzinger LM, Berridge BR, et al. Adipsin: a biomarker of gastrointestinal toxicity mediated by a functional \u03b3-secretase inhibitor. J Biol Chem. 2003;278:46107\u201316.","journal-title":"J Biol Chem"},{"key":"2744_CR47","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1021\/bi301137h","volume":"51","author":"CJ Crump","year":"2012","unstructured":"Crump CJ, Castro SV, Wang F, Pozdnyakov N, Ballard TE, Sisodia SS, et al. BMS-708,163 targets presenilin and lacks notch-sparing activity. Biochemistry. 2012;51:7209\u201311.","journal-title":"Biochemistry"},{"key":"2744_CR48","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1001\/jamaneurol.2015.0607","volume":"72","author":"V Coric","year":"2015","unstructured":"Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, et al. Targeting prodromal Alzheimer disease with avagacestat: a randomized clinical trial. JAMA Neurol. 2015;72:1324\u201333.","journal-title":"JAMA Neurol"},{"key":"2744_CR49","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1210951","volume":"369","author":"RS Doody","year":"2013","unstructured":"Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease. N Engl J Med. 2013;369:341\u201350.","journal-title":"N Engl J Med"},{"key":"2744_CR50","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/pro.3606","volume":"28","author":"MA Castro","year":"2019","unstructured":"Castro MA, Hadziselimovic A, Sanders CR. The vexing complexity of the amyloidogenic pathway. Protein Sci. 2019;28:1177\u201393.","journal-title":"Protein Sci"},{"key":"2744_CR51","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1523\/JNEUROSCI.4264-11.2012","volume":"32","author":"Y Mitani","year":"2012","unstructured":"Mitani Y, Yarimizu J, Saita K, Uchino H, Akashiba H, Shitaka Y, et al. Differential effects between \u03b3-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice. J Neurosci. 2012;32:2037\u201350.","journal-title":"J Neurosci"},{"key":"2744_CR52","first-page":"13627","volume":"7","author":"TR McCaw","year":"2020","unstructured":"McCaw TR, Inga E, Chen H, Jaskula-Sztul R, Dudeja V, Bibb JA, et al. Secretase inhibitors in cancer: a current perspective on clinical performance. Oncologist. 2020;7:13627.","journal-title":"Oncologist"},{"key":"2744_CR53","doi-asserted-by":"publisher","first-page":"E476","DOI":"10.1073\/pnas.1618657114","volume":"114","author":"L Sun","year":"2017","unstructured":"Sun L, Zhou R, Yang G, Shi Y. Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of A\u03b242 and A\u03b240 peptides by \u03b3-secretase. Proc Natl Acad Sci USA. 2017;114:E476\u2013E85.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2744_CR54","unstructured":"http:\/\/www.alzforum.org\/mutations."},{"key":"2744_CR55","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","volume":"29","author":"M Takami","year":"2009","unstructured":"Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima-Kawashima M, Funamoto S, et al. Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci. 2009;29:13042\u201352.","journal-title":"J Neurosci"},{"key":"2744_CR56","doi-asserted-by":"publisher","first-page":"9023","DOI":"10.1021\/bi2007146","volume":"50","author":"O Quintero-Monzon","year":"2011","unstructured":"Quintero-Monzon O, Martin MM, Fernandez MA, Cappello CA, Krzysiak AJ, Osenkowski P, et al. dissociation between the processivity and total activity of \u03b3-secretase: implications for the mechanism of Alzheimer\u2019s disease-causing presenilin mutations. Biochemistry. 2011;50:9023\u201335.","journal-title":"Biochemistry"},{"key":"2744_CR57","doi-asserted-by":"publisher","first-page":"31043","DOI":"10.1074\/jbc.M114.581165","volume":"289","author":"MA Fernandez","year":"2014","unstructured":"Fernandez MA, Klutkowski JA, Freret T, Wolfe MS. Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid \u03b2-peptides (Abeta) by \u03b3-secretase to increase 42-to-40-residue A\u03b2. J Biol Chem. 2014;289:31043\u201352.","journal-title":"J Biol Chem"},{"key":"2744_CR58","doi-asserted-by":"publisher","first-page":"100281","DOI":"10.1016\/j.jbc.2021.100281","volume":"296","author":"S Devkota","year":"2021","unstructured":"Devkota S, Williams TD, Wolfe MS. Familial Alzheimer\u2019s disease mutations in amyloid protein precursor alter proteolysis by \u03b3-secretase to increase amyloid \u03b2-peptides of >45 residues. J Biol Chem. 2021;296:100281.","journal-title":"J Biol Chem"},{"key":"2744_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.pmbts.2019.07.002","volume":"168","author":"MS Wolfe","year":"2019","unstructured":"Wolfe MS. In search of pathogenic amyloid \u03b2-peptide in familial Alzheimer\u2019s disease. Prog Mol Biol Transl Sci. 2019;168:71\u20138.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2744_CR60","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1021\/acs.jmedchem.5b01960","volume":"59","author":"MG Bursavich","year":"2016","unstructured":"Bursavich MG, Harrison BA, Blain JF. \u03b3-secretase modulators: new Alzheimer\u2019s drugs on the horizon? J Med Chem. 2016;59:7389\u2013409.","journal-title":"J Med Chem"},{"key":"2744_CR61","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/35102591","volume":"414","author":"S Weggen","year":"2001","unstructured":"Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, et al. A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity. Nature. 2001;414:212\u20136.","journal-title":"Nature"},{"key":"2744_CR62","doi-asserted-by":"publisher","first-page":"e20202560","DOI":"10.1084\/jem.20202560","volume":"218","author":"KD Rynearson","year":"2021","unstructured":"Rynearson KD, Ponnusamy M, Prikhodko O, Xie Y, Zhang C, Nguyen P, et al. Preclinical validation of a potent \u03b3-secretase modulator for Alzheimer\u2019s disease prevention. J Exp Med. 2021;218:e20202560.","journal-title":"J Exp Med"},{"key":"2744_CR63","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367:795\u2013804.","journal-title":"N Engl J Med"},{"key":"2744_CR64","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207\u201316.","journal-title":"Lancet Neurol"},{"key":"2744_CR65","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol. 2009;11:909\u201313.","journal-title":"Nat Cell Biol"},{"key":"2744_CR66","doi-asserted-by":"publisher","first-page":"112631","DOI":"10.1016\/j.ejmech.2020.112631","volume":"204","author":"V Span\u00f2","year":"2020","unstructured":"Span\u00f2 V, Venturini A, Genovese M, Barreca M, Raimondi MV, Montalbano A, et al. Current development of CFTR potentiators in the last decade. Eur J Med Chem. 2020;204:112631.","journal-title":"Eur J Med Chem"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-021-02744-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-021-02744-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-021-02744-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T18:55:57Z","timestamp":1675364157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-021-02744-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1007\/s00044-021-02744-3","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"type":"print","value":"1054-2523"},{"type":"electronic","value":"1554-8120"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}